SurRad



Neoprobe Gamma Probe
Neoprobe Gamma Probe

Emerging technology allows the journey through breast cancer treatment to be kinder, gentler and more effective—not to mention less costly.

For those diagnosed with Stage I or II breast cancer, you may qualify for SurRad™--the combination of surgery, radiation and reconstruction administered in one day.

Committed to wellness and health through education
and research for the prevention and cure of breast cancer.

Breast Cancer Treatment
...in a Day!

Name: A value is required. Email: A value is required.Invalid format.

NEWS COVERAGE

Breast Cancer Treatment in a Day

Veronesi Study

A European study, conducted by Dr. Umberto Veronesi (founder of the European Institute of Oncology), has recently announced that a single dose of intraoperative electron-beam radiation can be equal to the traditional six-week course for women with breast cancer. The only FDA-approved device manufactured in North America that is capable of delivering the IOERT treatment extolled by Dr. Veronesi in an unshielded operating room is the IntraOp Mobetron 1000. The Mobetron 1000 is a fully portable, self-shielded linear accelerator that can be used in an existing operating room.

PDF

Veronesi™ Study of 1200 Beast Cancer Patients

Power Point

Read the summary of Veronesi Results

PDF

Read the brochure on IOERT for Breast Cancer

PDF

Mobetron: Single Dose™ Breast Cancer Treatment Brochure

PDF

Nagoya University announces Single Dose Treatment

Power Point

Marketing File

To read Adobe PDF files you will require Adobe Acrobat Reader. If it is not installed, you can download it free from the Adobe Website.

Download Adobe Reader

View more about the Veronesi Study at INTRAOP Website.”